BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 31138789)

  • 1. Zinc-induced Dnmt1 expression involves antagonism between MTF-1 and nuclear receptor SHP.
    Zhang Y; Andrews GK; Wang L
    Nucleic Acids Res; 2012 Jun; 40(11):4850-60. PubMed ID: 22362755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential deregulation of histone marks, chromatin accessibility and gene expression in response to PROTAC-induced degradation of ASH2L.
    Barsoum M; Sayadi-Boroujeni R; Stenzel AT; Bussmann P; Lüscher-Firzlaff J; Lüscher B
    Sci Rep; 2023 Dec; 13(1):22565. PubMed ID: 38114530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ash2l interacts with Tbx1 and is required during early embryogenesis.
    Stoller JZ; Huang L; Tan CC; Huang F; Zhou DD; Yang J; Gelb BD; Epstein JA
    Exp Biol Med (Maywood); 2010 May; 235(5):569-76. PubMed ID: 20463296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olsalazine pretreatment augments chemosensitivity of gemcitabine in hepatocellular carcinoma.
    Sharma A; Chhipa AS; Verma S; Parikh P; Patel S
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23737. PubMed ID: 38798245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASH2L Mediates Epidermal Differentiation and Hair Follicle Morphogenesis through H3K4me3 Modification.
    Wang Q; Zeng S; Liang Y; Zhou R; Wang D
    J Invest Dermatol; 2024 Apr; ():. PubMed ID: 38582368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional role of Ash2l in oxLDL induced endothelial dysfunction and atherosclerosis.
    Su Z; Wang J; Xiao C; Zhong W; Liu J; Liu X; Zhu YZ
    Cell Mol Life Sci; 2024 Jan; 81(1):62. PubMed ID: 38280036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3ε: a protein with complex physiology function but promising therapeutic potential in cancer.
    Zhang Y; Yan M; Yu Y; Wang J; Jiao Y; Zheng M; Zhang S
    Cell Commun Signal; 2024 Jan; 22(1):72. PubMed ID: 38279176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASH2L upregulation contributes to diabetic endothelial dysfunction in mice through STEAP4-mediated copper uptake.
    Zhong W; Dong YJ; Hong C; Li YH; Xiao CX; Liu XH; Chang J
    Acta Pharmacol Sin; 2024 Mar; 45(3):558-569. PubMed ID: 37903897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L.
    Liu W; Hu D; Li J; Xu Q; Chen Z; Xu B
    Cancer Biol Ther; 2023 Dec; 24(1):2216041. PubMed ID: 37287122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitis.
    Li X; Zhong S; Sun Y; Huang X; Li Y; Wang L; Wu Y; Yang M; Yuan HX; Liu J; Zang S
    Front Endocrinol (Lausanne); 2022; 13():951093. PubMed ID: 36329886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental Programming: Prenatal Testosterone Excess on Liver and Muscle Coding and Noncoding RNA in Female Sheep.
    Saadat N; Puttabyatappa M; Elangovan VR; Dou J; Ciarelli JN; Thompson RC; Bakulski KM; Padmanabhan V
    Endocrinology; 2022 Jan; 163(1):. PubMed ID: 34718504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative Analysis of Metallothioneins Identifies MT1H as Candidate Prognostic Biomarker in Hepatocellular Carcinoma.
    Zhang F; Guo S; Zhong W; Huang K; Liu Y
    Front Mol Biosci; 2021; 8():672416. PubMed ID: 34676244
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduced Expression of Metallothionein-I/II in Renal Proximal Tubules Is Associated with Advanced Chronic Kidney Disease.
    Lu YJ; Wu YJ; Chen LJ; Ko BS; Chang TC; Wu YJ; Liang SM; Jan YJ; Liou JY
    Toxins (Basel); 2021 Aug; 13(8):. PubMed ID: 34437439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Potential Biomarkers From Hepatocellular Carcinoma With MT1 Deletion.
    Zhang R; Huang M; Wang H; Wu S; Yao J; Ge Y; Lu Y; Hu Q
    Pathol Oncol Res; 2021; 27():597527. PubMed ID: 34257549
    [No Abstract]   [Full Text] [Related]  

  • 15. ASH2L drives proliferation and sensitivity to bleomycin and other genotoxins in Hodgkin's lymphoma and testicular cancer cells.
    Constantin D; Widmann C
    Cell Death Dis; 2020 Nov; 11(11):1019. PubMed ID: 33257682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RICTOR/mTORC2 affects tumorigenesis and therapeutic efficacy of mTOR inhibitors in esophageal squamous cell carcinoma.
    Lu Z; Shi X; Gong F; Li S; Wang Y; Ren Y; Zhang M; Yu B; Li Y; Zhao W; Zhang J; Hou G
    Acta Pharm Sin B; 2020 Jun; 10(6):1004-1019. PubMed ID: 32642408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PretiMeth: precise prediction models for DNA methylation based on single methylation mark.
    Tang J; Zou J; Zhang X; Fan M; Tian Q; Fu S; Gao S; Fan S
    BMC Genomics; 2020 May; 21(1):364. PubMed ID: 32414326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma.
    Wu YJ; Ko BS; Liang SM; Lu YJ; Jan YJ; Jiang SS; Shyue SK; Chen L; Liou JY
    Cell Death Dis; 2019 May; 10(6):408. PubMed ID: 31138789
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.